Shares of SpringWorks Therapeutics, Inc. SWTX surged in pre-market trading after the company reported the FDA approval of OGSIVEO (nirogacestat) as the first and only treatment for adults with desmoid tumors.
SpringWorks Therapeutics shares rose 14.4% to $23.77 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
- SaverOne 2014 Ltd SVRE shares rose 74.8% to $0.7389 in pre-market trading. SaverOne announced withdrawal of proposed public offering due to market conditions.
- ESGL Holdings Limited ESGL shares rose 54.3% to $1.38 in pre-market trading after the company disclosed a multi-year contract renewal with Singapore Refining Company Private Limited.
- Heart Test Laboratories, Inc. HSCS rose 27.5% to $0.2735 in pre-market trading. Heart Test Laboratories 13G filing showed Icahn School of Medicine at Mount Sinai ("ISMMS") EIN 13-6171197 reported a 9.9% stake in the company, as of Nov. 16, 2023.
- RedHill Biopharma Ltd. RDHL shares surged 21% to $1.21 in pre-market trading. Redhill Biopharma shares jumped 217% on Monday after the company announced the FDA has granted five years' market exclusivity for Talicia.
- Sunshine Biopharma, Inc. SBFM gained 18.2% to $0.2910 in pre-market trading after falling around 12% on Monday. The company recently posted a narrower-than-expected quarterly loss.
- TC Biopharm (Holdings) Plc TCBP shares rose 10.3% to $0.4633 in pre-market trading after falling more than 25% on Monday. TC Biopharm announced FDA clearance of the Phase 1B IND for TCB-008 in Acute Myeloid Leukemia.
- Alithya Group Inc. ALYA shares gained 9.6% to $1.26 in pre-market trading. The company recently posted an increase in third-quarter sales.
- Starbox Group Holdings Ltd. STBX shares climbed 9% to $0.3290 in pre-market trading after dipping 15% on Monday.
- Professional Diversity Network, Inc. IPDN gained 7.7% to $1.68 in pre-market trading after gaining around 24% on Monday. Professional Diversity recently posted a narrower quarterly loss.
Losers
- Tharimmune, Inc. THAR dipped 67.4% to $1.14 in pre-market trading. Tharimmune priced its $10 million public offering 10 million common shares at $1 per share.
- SenesTech, Inc. SNES shares fell 35.1% to $1.20 in pre-market trading after the company reported pricing of $5.0 million public offering.
- CohBar, Inc. CWBR fell 33.4% to $0.5997 in pre-market.
- Next.e.GO N.V. EGOX shares fell 19.5% to $0.4426 in pre-market trading after gaining around 8% on Monday.
- Nexalin Technology, Inc. NXL shares fell 19.3% to $0.2712 in pre-market trading.
- Mobiquity Technologies, Inc. MOBQ fell 15.3% to $0.3912 in pre-market trading.
- argenx SE ARGX fell 14.4% to $423.80 in pre-market trading after the company reported topline results from ADVANCE-SC study of VYVGART hytrulo in primary immune thrombocytopenia.
- Yield10 Bioscience, Inc. YTEN shares fell 13.6% to $0.21 in pre-market trading. Maxim Group recently downgraded Yield10 Bioscience from Buy to Hold.
- GlucoTrack, Inc. GCTK shares fell 8.3% to $0.1898 in pre-market trading after gaining 7% on Monday.
- Asset Entities Inc. ASST fell 7.4% to $0.6125 in pre-market trading. Asset Entities shares jumped over 88% on Monday after the company announced a stock repurchase program.
Now Read This: Intuit, NetApp And 3 Stocks To Watch Heading Into Tuesday
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in